UNSPSC 51162025: Ephedrine/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162025 Ephedrine/phenobarbital is a Commodity code that captures pharmaceutical products and related health-care delivery services state and local governments procure to support community health, emergency response, and employee wellness programs. Recent solicitations under this code show procurement of naloxone and drug deactivation systems for public health initiatives, as well as on-site pharmacy services supporting employee and retiree health insurance plans. Issuing bodies include county health departments and county government benefits administrators. The work involves both the supply of specific pharmaceutical products and the delivery of broader pharmacy management services, including formulary stocking, dispensing, and cost management across multiple therapeutic categories.

Activity under the code spans Florida and Georgia. Seminole County, Florida issued IFB 60459723LAS in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 at 2:00 p.m. Hall County, Georgia issued RFQ/P #47-010 in May 2026 to procure on-site pharmacy services at the Hall County Government Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible individuals across multiple insurance plans, with a June 4, 2026 submission deadline at 2:00 p.m. Eastern Time and an initial contract term beginning January 1, 2027 with four optional one-year renewals. Both procurements require vendors to carry insurance, comply with E-Verify, and deliver comprehensive documentation; neither specifies set-asides for disadvantaged enterprises.